The document describes several sulfonamide antibiotics including their class, mechanism of action, absorption, distribution, metabolism, excretion, toxicity/side effects, and uses. Sulfonamides work by inhibiting the incorporation of para-aminobenzoic acid (PABA) into dihydropteric acid, thereby inhibiting folic acid synthesis and exerting a bacteriostatic effect. They are absorbed in the GI tract and distributed widely throughout the body, including crossing the placenta. Metabolism involves acetylation in the liver and excretion is primarily through renal filtration and secretion. Common side effects include hypersensitivity reactions, urinary tract disturbances, and hematopoietic disorders. Sulfonamides
Pharmacology of Penicllins (Beta lactam antibiotics), description of their mechanism of action, mechanism of resistance, classification, indications and adverse effects
As new scientific information becomes available through basic and clinical research, recommended treatments and drug therapies undergo changes. The author(s) and publisher have done everything possible to make this book accurate, up to date, and in accord with accepted standards at the time of publication. The author(s), editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of the book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised always to check product information (package inserts) for changes and new information regarding dose and contraindications before administering any drug. Caution is especially urged when using new or infrequently ordered drugs.
Pharmacology of Penicllins (Beta lactam antibiotics), description of their mechanism of action, mechanism of resistance, classification, indications and adverse effects
As new scientific information becomes available through basic and clinical research, recommended treatments and drug therapies undergo changes. The author(s) and publisher have done everything possible to make this book accurate, up to date, and in accord with accepted standards at the time of publication. The author(s), editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of the book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised always to check product information (package inserts) for changes and new information regarding dose and contraindications before administering any drug. Caution is especially urged when using new or infrequently ordered drugs.
Anthelmintic
According to the syllabus based on “PHARMACY COUNCIL OF INDIA”
“I Dedicate this work to all the
Students , Pharmacy Faculty & Family Members
Drx. Shubhanshu R.s. Jaiswal
Helminthiasis also known as Worm Infection, is any macro parasitic disease of humans & other animals in which a Part of the body is infected with parasitic worms, known as Helminths.
LUMEN DWELLING FLAGELLATES - GIARDIA
REFS:
INTERNATIONALLY ACCEPTED BOOK OF MEDICAL PARASITOLOGY BY K. D. CHATTERJEE
TEXT BOOK OF MEDICAL PARASITOLOGY BY PANIKER
IMAGE SOURCES : FROM INTERNET
Anthelmintic
According to the syllabus based on “PHARMACY COUNCIL OF INDIA”
“I Dedicate this work to all the
Students , Pharmacy Faculty & Family Members
Drx. Shubhanshu R.s. Jaiswal
Helminthiasis also known as Worm Infection, is any macro parasitic disease of humans & other animals in which a Part of the body is infected with parasitic worms, known as Helminths.
LUMEN DWELLING FLAGELLATES - GIARDIA
REFS:
INTERNATIONALLY ACCEPTED BOOK OF MEDICAL PARASITOLOGY BY K. D. CHATTERJEE
TEXT BOOK OF MEDICAL PARASITOLOGY BY PANIKER
IMAGE SOURCES : FROM INTERNET
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
1. Name: Sulfisoxazole (Gantrisin) Name: Sulfamethoxazole (Gantanol)
Class: Sulfonamide Class: Sulfonamide
Mech.: Comp. inhib. of PABA incorp. into dihydropteric acid → inhib. of folic acid. Mech.: Comp. inhib. of PABA incorp. into dihydropteric acid → inhib. of folic
Bacteriostatic. acid. Bacteriostatic.
Absorption: Rapidly absorbed in GI tract. Parenteral. Absorption: Rapidly absorbed in GI tract (slower than isoxazole). Parenteral.
Distribution: Widely distrib; CSF. Crosses placenta. Distribution: Widely distrib; limited CSF. Crosses placenta.
Metab.: Acetylated in liver Metab.: Acetylated in liver
Excretion, t_: Renal filtration, secretion Excretion, t_: Renal filtration, secretion
Toxicity/S.E.s: Hypersensitivity—fever, rash, photosensitivity; UT disturbances— Toxicity/S.E.s: Hypersensitivity—fever, rash, photosensitivity; UT
deposition of crystalline aggregates; hematopoetic disturbances— deposition of crystalline aggregates;
disorders—dyscrasias hematopoetic disorders—dyscrasias
Utility: Uncomplicated UTIs, trachoma (contag. disease of eyelid, conjunct, Utility: Uncomplicated UTIs, trachoma (contag. disease of eyelid, conjunct,
cornea), nocardiosis (tuberculosis-like infect.), prophylaxis (burnt skin, cornea), nocardiosis (tuberculosis-like infect.), prophylaxis (burnt skin,
suppressing recurring UTIs, rheumatic fever) suppressing recurring UTIs, rheumatic fever)
Special Features: Spectrum—gram +, gram -. Less renal toxicity than other Special Features: Spectrum—gram +, gram -.
sulfas. Protoype.
Name: Sulfadiazine Name: Sulfasalazine (Azulfidine)
Class: Sulfonamide Class: Sulfonamide
Mech.: Comp. inhib. of PABA incorp. into dihydropteric acid → inhib. of folic acid. Mech.: Comp. inhib. of PABA incorp. into dihydropteric acid → inhib. of folic
Bacteriostatic. acid.
Absorption: Rapidly absorbed in GI tract. Parenteral. Absorption: Poorly absorbed in GI tract.
Distribution: Widely distrib; good CSF. Crosses placenta. Distribution: GI tract
Metab.: Acetylated in liver Metab.: Hydrolized to active form by intest. bacteria.
Excretion, t_: Renal filtration, secretion Excretion, t_: feces
Toxicity/S.E.s: Hypersensitivity—fever, rash, photosensitivity; UT disturbances— Toxicity/S.E.s: Interferes w/normal flora → ↓ vit. K synth.
deposition of crystalline aggregates; hematopoetic
disorders—dyscrasias Utility: Active in bowel lumen. Used prior to surgery to reduce microbe
population. Treat inflammatory bowel disease, rheumatoid arthritis
Utility: Uncomplicated UTIs, trachoma (contag. disease of eyelid, conjunct,
cornea), nocardiosis (tuberculosis-like infect.), prophylaxis (burnt skin, Special Features: Broken down in intestines to liberate 5-aminosalicylate (anti-
suppressing recurring UTIs, rheumatic fever) inflammatory).
Special Features: Spectrum—gram +, gram -.
www.brain101.info
1
2. Name: Silver Sulfadiazine (Silvadene) Name: Sulfacetamide sodium (Sulamyd Sodium)
Class: Sulfonamide Class: Sulfonamide
Mech.: Releases silver → toxicity for bacteria and fungi. Mech.: Comp. inhib. of PABA incorp. into dihydropteric acid → inhib. of folic
Absorption: acid.
Distribution: Topical Absorption:
Metab.: Distribution: Ophthalmic application. Penetrates into ocular fluids at high conc.
Excretion, t_: Metab.:
Toxicity/S.E.s: Excretion, t_:
Utility: Used topically to reduce infection of burns, but not to treat established Toxicity/S.E.s:
infections. Utility: Ophthalmic infections
Special Features: Special Features: High aqueous concentrations are not irritating.
Name: Trimethoprim-Sulfamethoxazole (Bactrim, Septra) Name: Chloramphenicol (Chloromycetin)
Class: Class:
Mech.: Acts on two sequential steps in synth of folic acid. PABA competitive Mech.: Bacteriostatic. Inhib protein synth by binding to 50S subunit.
inhib, dihydrofolate reductase inhib. Bacteriostatic. Absorption: Rapid oral absorption
Absorption: Oral, IV Distribution: Body fluids, good CSF. Crosses placenta. Milk.
Distribution: Metab.: Liver (glucuronyl transferase)
Metab.: Excretion, t_: Urine (filtration, secretion), 1.5-3.5 hr.
Excretion, t_: Toxicity/S.E.s: Bone marrow depression (anemia, leukopenia, thrombocytopenia,
Toxicity/S.E.s: Megaloblastic anemia, leukopenia, granulocytopenia (prevented prob. due to inhib. of mitoch. protein), aplastic anemia
by admin. of folic acid) (allergic/idiosync, rare, irreversible, often fatal), Gray Baby
Utility: Uncomp. UTIs, otitis media, acute exacerbations of chronic bronchitis, Syndrome (neonate overdose due to reduced ability to conjuate
various pneumonias. DOC for Travelers’ diarrhea, P. carinii pneumonia, CA and secrete metabolites), superinfection (S. aureus,
Shigella enteritis, systemic Salmonella infects, prostatitis. Pseudomonas, fungi, can be life threatening).
Special Features: Trimethoprim = highly selective inhib. of bacterial dihydrofolate Utility: DOC for severe Bacteroides infects (esp. CNS), backup for memingitis,
reductase. rickettsial infects, brucellosis.
Special Features: Never use if safer antibiotic avail. Never use for mild infects.
www.brain101.info
2
3. Name: Tetracycline (Achromycin V) Name: Doxycycline (Vibramycin)
Class: Tetracycline Class: Tetracycline
Mech.: Active uptake into bacteria →inhib protein synth by binding to 30S Mech.: Active uptake into bacteria →inhib protein synth by binding to 30S
ribosome. Bacteriostatic ribosome. Bacteriostatic
Absorption: Oral adequate, but incomplete. Impaired by divalent cations. IM Absorption: Good oral absorption. Impaired by divalent cations. IM painful. IV
painful. IV may cause thrombophlebitis. Never intrathecal. may cause thrombophlebitis. Never intrathecal.
Distribution: Good CSF. Conc. in liver → enterohepatic circ. Penetrates most Distribution: Good CSF. Conc. in liver → enterohepatic circ. Penetrates most
tissues and fluids. Crosses placenta. tissues and fluids. Crosses placenta.
Metab.: Metab.:
Excretion, t_: filtration (1°), bile Excretion, t_: bile; doesn’t require renal excretion
Toxicity/S.E.s: GI — burning, discomfort, nausea, vomitiing; superinfection — due to broad Toxicity/S.E.s: GI — burning, discomfort, nausea, vomitiing; superinfection — due to broad
spectrum, candida albicans (1°), staph enterocolitis, pseudomemb. colitis; spectrum, candida albicans (1°), staph enterocolitis, pseudomemb. colitis;
hepatotoxicity (esp. in pregnancy); renal toxicity; Fanconi synd.; perm. brown hepatotoxicity (esp. in pregnancy); renal toxicity; Fanconi synd.; perm. brown
discoloration of teeth; slowing of bone growth; phototoxicity; thrombophlebitis; discoloration of teeth; slowing of bone growth; phototoxicity (more than others);
hematopoetic changes; rare hypersens. rxns. thrombophlebitis; hematopoetic changes; rare hypersens. rxns.
Utility: gram - cocci, gram - bacilli, acid fast bacilli, chlamydiae, mycoplasma, Utility: gram - cocci, gram - bacilli, acid fast bacilli, chlamydiae, mycoplasma,
rickettsia, spirochetes. No effect on viruses or fungi. Also used for rickettsia, spirochetes. No effect on viruses or fungi. Also used for
acne, prophylaxis for Travelers’ diarrhea. acne, prophylaxis for Travelers’ diarrhea.
Special Features: Broad spectrum. Decreased effect of oral contraceptives. Special Features: Broad spectrum. Decreased effect of oral contraceptives.
Name: Minocyclin (Minocin) Name: Penicillin G
Class: Tetracycline
Class: Penicillin (Penicillin G-related)
Mech.: Active uptake into bacteria →inhib protein synth by binding to 30S
ribosome. Bacteriostatic Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
Absorption: Good oral absorption. Impaired by divalent cations. IM cell wall formation. Bactericidal.
painful. IV may cause thrombophlebitis. Never intrathecal. Absorption: Erratic (30%). Usu. not used orally. I.M or I.V. Prolonged effect
Distribution: Good CSF. Conc. in liver → enterohepatic circ. Penetrates most with repository preparations (procaine, benzathine (longest)) deep
tissues and fluids. Also enters tears and saliva. Crosses placenta. IM.
Metab.: Liver, but not critical. Distribution: Widely distributed, little CSF unless meninges inflamed.
Excretion, t_: bile; doesn’t require renal excretion Metab.:
Toxicity/S.E.s: Vestibular toxicity; GI — burning, discomfort, nausea, vomitiing; superinfection —
due to broad spectrum, candida albicans (1°), staph enterocolitis, pseudomemb. Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt.
colitis; hepatotoxicity (esp. in pregnancy); renal toxicity; Fanconi synd.; perm. in bile.
brown discoloration of teeth; slowing of bone growth; phototoxicity; Toxicity/S.E.s: hypersensitivity (1-10%), painful injection, epilepsy,
thrombophlebitis; hematopoetic changes; rare hypersens. rxns. superinfection.
Utility: gram - cocci, gram - bacilli, acid fast bacilli, chlamydiae, mycoplasma,
rickettsia, spirochetes. No effect on viruses or fungi. Also used for Utility: Many gram +, anaerobes, and a few gram -. Most staph. and gram -
acne, prophylaxis for Travelers’ diarrhea. resistant. Prophylactic use (rheumatic fever, strep. infections).
Special Features: Broad spectrum. Decreased effect of oral contraceptives. Special Features: Narrow spectrum.
www.brain101.info
3
4. Name: Penicillin V Name: Nafcillin (Nafcil)
Class: Penicillin (Penicillin G-related) Class: Penicillin (Penicillinase-resistant)
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
cell wall formation. Bactericidal. cell wall formation. Bactericidal.
Absorption: Acid stable → good oral absortption. Absorption: Poor oral. Usu. IV for seious infections. IM.
Distribution: Widely distributed, little CSF unless meninges inflamed. Distribution: Widely distributed, little CSF unless meninges inflamed.
Metab.: Metab.:
Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt. Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt.
in bile. in bile.
Toxicity/S.E.s: : hypersensitivity (1-10%), superinfection. Toxicity/S.E.s: hypersensitivity (1-10%), superinfection.
Utility: Mild to moderate infections only: Many gram +, anaerobes, and a few gram Utility: Penicillinase-producing staph. infections. Gram +.
-. Most staph. and gram - resistant. Same spectrum as Pen. G, but less Special Features: Narrow spectrum. Prob. most effective penicillinase-resist.
active.
Special Features: Narrow spectrum.
Name: Methicillin (Staphcillin) Name: Oxacillin (Bactocill)
Class: Penicillin (Penicillinase-resistant) Class: Penicillin (Penicillinase-resistant)
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
cell wall formation. Bactericidal. cell wall formation. Bactericidal.
Absorption: Usu. IV for seious infections. IM. Absorption: Acid stable. Absorbed orally. IM, IV.
Distribution: Widely distributed, little CSF unless meninges inflamed. Distribution: Widely distributed, little CSF unless meninges inflamed.
Metab.: Metab.:
Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt. Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt.
in bile. in bile.
Toxicity/S.E.s: hypersensitivity (1-10%), superinfection. Toxicity/S.E.s: hypersensitivity (1-10%), superinfection.
Utility: Penicillinase-producing staph. infections. Gram +. Utility: Penicillinase-producing staph. infections. Mild infections.
Special Features: Narrow spectrum. Special Features: Narrow spectrum.
www.brain101.info
4
5. Name: Ampicillin (Omnipen, Polycillin) Name: Amoxicillin (Amoxil)
Class: Penicillin (Aminopenicillin) Class: Penicillin (Aminopenicillin)
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
cell wall formation. Bactericidal. cell wall formation. Bactericidal.
Absorption: Acid stable. Good oral, but food interferes. IM, IV. Absorption: Acid stable. Good oral (better than ampicillin).
Distribution: Widely distributed, little CSF unless meninges inflamed. Distribution: Widely distributed, little CSF unless meninges inflamed.
Metab.: Metab.:
Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt. Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt.
in bile. in bile.
Toxicity/S.E.s: diarrhea, non-allergy skin rash, hypersensitivity (1-10%), Toxicity/S.E.s: diarrhea (less than ampicillin), hypersensitivity (1-10%),
superinfection. superinfection.
Utility: More effective against gram -s (esp. Proteus, H. influenzae, E. coli, P. Utility: More effective against gram -s (esp. Proteus, H. influenzae, E. coli, P.
mirabilis). Less active than Pen. G against gram+ cocci. mirabilis). Less active than Pen. G against gram+ cocci.
Special Features: Broad spectrum. Special Features: Broad spectrum.
Name: Ticarcillin (Ticar) Name: Clavulanic acid
Class: Penicillin (Extended spectrum) Class: β-Lactamase Inhibitor
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
Mech.: inhibits some β-lactamases
cell wall formation. Bactericidal.
Absorption: IM, IV. Absorption:
Distribution: Widely distributed, little CSF unless meninges inflamed. Distribution:
Metab.: Metab.:
Excretion, t_: Rapidly elim. by kidneys (probenecid blocks excretion), small amt. Excretion, t_:
in bile. Toxicity/S.E.s:
Toxicity/S.E.s: hypersensitivity (1-10%), superinfection., coagulation disorders. Utility: Combined with amoxicillin (Augmentin) to increase efficacy against
Utility: Gram -. Effective against Pseudomonas, Proteus mirabilus, often used penicillinase-producing bacteria (i.e., staph.)
w/aminoglyc. Special Features:
Special Features: Narrow spectrum. Resistance develops quickly.
www.brain101.info
5
6. Name: Sulbactam Name: Probenecid
Class: β-Lactamase Inhibitor Class:
Mech.: Interferes w/renal excretion of drugs that undergo tubular secretion.
Mech.: inhibits some β-lactamases
Inhib. glucuronide conjugation of other drugs.
Absorption: Absorption:
Distribution: Distribution:
Metab.: Metab.:
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: Toxicity/S.E.s:
Utility: Combined with ampicillin (Unasyn-sulbactam) to increase efficacy against Utility:
penicillinase-producing bacteria (i.e., staph).
Special Features: Decreases renal excretion of methotrexate — possible
Special Features: toxicity. Decreases renal excretion of penicillin.
Name: Cephalothin (Keflin) Name: Cephalexin (Keflex)
Class: First Gen. Cephalosporin Class: First Gen. Cephalosporin
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
cell wall formation. Bactericidal. cell wall formation. Bactericidal.
Absorption: IV. IM rarely used due to pain. Absorption: Oral.
Distribution: Poor CSF. Distribution: Poor CSF.
Metab.: Metab.:
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: Hypersensitivity (some cross-sensitivity to pen.), superinfection, Toxicity/S.E.s: Hypersensitivity (some cross-sensitivity to pen.), superinfection,
renal damage (worse if comb. w/aminoglycs.) renal damage (worse if comb. w/aminoglycs.)
Utility: Usu not DOC. Serious Klebsiella infects., strep/staph infects, some Utility: Usu not DOC. Serious Klebsiella infects., strep/staph infects, some
penicillinase-producing bacteria. penicillinase-producing bacteria.
Special Features: Narrow spectrum. Greater gram - activity than pen. G. More Special Features: Narrow spectrum. Greater gram - activity than pen. G. More
gram+ activity than gram - activity. Less susceptible to β- gram+ activity than gram - activity. Less susceptible to β-
lactamase than most penicillins. lactamase than most penicillins.
www.brain101.info
6
7. Name: Cefoxitin (Mefoxin) Name: Cefaclor (Ceclor)
Class: Second Gen. Cephalosporin Class: Second Gen. Cephalosporin
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
cell wall formation. Bactericidal. cell wall formation. Bactericidal.
Absorption: IV. IM rare due to pain. Absorption: Oral.
Distribution: Poor CSF. Distribution: Poor CSF.
Metab.: Metab.:
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: Hypersensitivity (some cross-sensitivity to pen.), superinfection, Toxicity/S.E.s: Hypersensitivity (some cross-sensitivity to pen.), superinfection,
renal damage (worse if comb. w/aminoglycs.) renal damage (worse if comb. w/aminoglycs.)
Utility: Mixed anaerobic infects. Utility: Resp. and middle ear infections (H. influenzae, M. catarrhalis)
Special Features: More gram- efficacy than first gen. Less gram+ cocci efficacy Special Features: More gram- efficacy than first gen. Less gram+ cocci efficacy
than first gen. ↑ β-lactamase resistance. than first gen. ↑ β-lactamase resistance. Problem
w/bacterial resistance.
Name: Cefotaxime (Claforan) Name: Cefixime (Suprax)
Class: Third Gen. Cephalosporin Class: Third Gen. Cephalosporin
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
cell wall formation. Bactericidal. cell wall formation. Bactericidal.
Absorption: IV Absorption: Oral
Distribution: good CSF Distribution: poor CSF
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: Hypersensitivity (some cross-sensitivity to pen.), superinfection, Toxicity/S.E.s: Hypersensitivity (some cross-sensitivity to pen.), superinfection,
renal damage (worse if comb. w/aminoglycs.) renal damage (worse if comb. w/aminoglycs.)
Utility: Serious nosocomial gram- sepsis. Meningitis caused by gram- enteric Utility: Serious nosocomial gram- sepsis. Serious Klebsiella infects., strep/staph
bacteria or H. influenzae. Serious Klebsiella infects., strep/staph infects, infects, some penicillinase-producing bacteria. Nosocomial infects.
some penicillinase-producing bacteria. Nosocomial infects. Often used Often used in comb. w/aminoglycosides.
in comb. w/aminoglycosides. Special Features: Decreased efficacy against gram+ cocci. Broader gram-
Special Features: Decreased efficacy against gram+ cocci. Broader gram- spectrum. More resistance against β-lactamases than
spectrum. More resistance against β-lactamases than second generation. Problem w/bacterial resistance.
second generation. Problem w/bacterial resistance.
www.brain101.info
7
8. Name: Imipenem Name: Aztreonam (Azactam)
Class: β-lactam (Carbapenem) Class: β-lactam (Monobactam)
Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of Mech.: Binds to PBPs, blocks activity of transpeptidases in terminal stages of
cell wall formation. Bactericidal. cell wall formation. Bactericidal.
Absorption: Oral, IV (painful) Absorption:
Distribution: Distribution:
Metab.: Metab.:
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: painful injection, allergy, nausea/vomiting, superinfection Toxicity/S.E.s: Gram+ superinfections.
(diarrhea), reversible blood disorders. Utility: Infections caused by susceptible orgs. resistant to other drugs.
Utility: Combined w/equal amts of cilastatin to block tubular metab. and formation Special Features: Not fused bicyclic. Potent gram-, but limited spectrum (only
of nephrotoxic compounds. Treats serious nosocomial infections, aerobics and facultative gram-). Little cross-allergenicity
infections of unknown etiology, mixed infections. w/pen. or ceph. Less toxic than aminoglycs. Usu used in
Special Features: Broadest spectrum of all β-lactams. Resistant to penicillinases combinations (except for UTIs).
and most β-lactamases. Resistance develops during
treatment.
Name: Methenamine Name: Nitrofurantoin (Furadantin)
Class: UTI Agent Class: UTI Agent
Mech.: Decomposes at pH ≤5.5 to NH4+ and formaldehyde (bactericidal). Mech.: Unclear. Baceria activate nitrofurantoin more rapidly than do mammalian
cells. Bacteriostatic in low conc., cidal in high conc.
Absorption: Oral very good, but ↓ pH of stomach decomposes lots of the drug.
Absorption: Rapidly and completely absorbed after oral admin.
Enteric-coated tablet solves most of problem.
Distribution: Antibact. conc. not achieved in plasma. Active in urine.
Distribution: Activated 1° in urine.
Metab.:
Metab.: NH4+ production requires fxning liver for excretion. Kidneys only Excretion, t_:
important if methenamine mandelate or hippurate is used.
Toxicity/S.E.s: GI effects, pulm. toxicity (acute pneumoinitis, subacute
Excretion, t_: Excreted in urine. NH4+ reduced requires liver for excretion. interstitial pulonary fibrosis), hypersensitivity rxns. chronic
Toxicity/S.E.s: GI distress. Long term = rash, hematuria, albuminuria, hepatitis, neuro efffects. Turns urine brown. Not for preg.
painful/frequent micturition. women or infants (hemolytic anemia). Not to be mixed
Utility: Chronic suppression of UTIs. w/probenecid.
Special Features: No resistance formation. Orgs which raise urine pH inhibit Utility: Uncomplicated lower UTIs caused by E. coli, Enteroccus, prevention of
formaldehyde formation → ↓ sensitivity. recurrence of UTIs.
Special Features: Effect enhanced by urine pH≤5.5.
www.brain101.info
8
9. Name: Cinoxacin (Cinobac) Name: Ciprofloxacin (Cipro)
Class: Nonfluorinated quinolone Class: Fluorinated quinolone
Mech.: Inhib bact. DNA gyrase (topoisomerase II). Bactericidal. Mech.: Inhib bact. DNA gyrase (topoisomerase II). Bactericidal.
Absorption: Oral Absorption: Rapid absorption after oral admin.
Distribution: Distribution: Good tissue penetration. Poor CSF.
Metab.: Metab.: Partial hepatic metab.
Excretion, t_: Excretion, t_: Glomerular filtration, secretion. Also feces, bile, sputum. 4 hrs.
Toxicity/S.E.s: Usu. not severe. GI, CNS. Not for pregnant or nursing women Toxicity/S.E.s: Usu. not severe. GI, CNS, arthropathy. Not for pregnant or
or prepubertal children. nursing women or prepubertal children.
Utility: UTIs due to coliform bacteria Utility: Upper and lower UTIs, DOC for Pseudomonas UTIs. Active against
Special Features: aerobic gram- bacilli, H. influenzae, Neisseria. Good alternate. for
several causes of infectious diarrhea, osteomyelitis, and patients w/CF.
Special Features: Broader spectrum than nonfluorinated quinolones.
Name: Norfloxacin (Noroxin) Name: Phenazopyridine (Pyridium)
Class: Fluorinated quinolone Class: Analgesic (not an antibiotic)
Mech.: Inhib bact. DNA gyrase (topoisomerase II). Bactericidal. Mech.: Analgesic effect on urinary tract mucosa.
Absorption: Oral admin. Absorption:
Distribution: Good tissue penetration. Distribution:
Metab.: Metab.:
Excretion, t_: Excretion, t_: 90% excreted in urine w/in 24 hrs.
Toxicity/S.E.s: Usu. not severe. GI, CNS. Not for pregnant or nursing women Toxicity/S.E.s: GI, headaches. Not for use w/renal insufficiency or severe
or prepubertal children. hepatitis. Hemolytic anemia. Cancer in rats. Stains urine,
Utility: UTIs due to Enterobacteriaceae, Enteroccus, Staph, Pseudomonas. skin, sclera, and contact lenses red-orange.
Special Features: Broader spectrum than nonfluorinated quinolones. Utility: Relief of dysuria and urethral irritation assoc. w/acute cystitis, trauma,
surgery, catheterization, endoscopy.
Special Features: When used w/antibacterial agent, should be discontinued after
48 hr. Should never be used on long-term basis to mask
undiagnosed urinary tract pain.
www.brain101.info
9
10. Name: Streptomycin Name: Neomycin (Mycifradin)
Class: Aminoglycoside Class: Aminoglycoside
Mech.: O2 dependent uptake → inhib. of protein synth by binding to 30S rib. Mech.: O2 dependent uptake → inhib. of protein synth by binding to 30S rib.
subunit → leaky membranes. Bactericidal. subunit → leaky membranes. Bactericidal.
Absorption: Poor oral absorption. Usu. IM or IV. Absorption: Very little oral absorption. Topical.
Distribution: Limited to extracellular space. Poor CSF, ocular. No placenta. Distribution: Limited to extracellular space. Poor CSF, ocular. No placenta.
Excretion, t_: glomerular filtration. 2 hrs. Excretion, t_:
Toxicity/S.E.s: Ototoxicity. Vestibular toxicity. Low nephrotoxicity. Toxicity/S.E.s: Parenteral → severe ototoxicity and nephrotoxicity.
Utility: Used in comb. therapy for tuberculosis. Used alone for bubonic plague Utility: Topical treatment of superf. sensitive skin and eye infections.
and tularemia. Preoperative prophylaxis for bowel surgery.
Special Features: Resistance 1° due to plasmid-med. mod. of aminoglyc. Also Special Features: Resistance 1° due to plasmid-med. mod. of aminoglyc. Also
alter. of transport system, mutation of rib. subunit. alter. of transport system, mutation of rib. subunit.
Name: Gentamicin (Garamycin) Name: Tobramycin (Nebcin)
Class: Aminoglycoside Class: Aminoglycoside
Mech.: O2 dependent uptake → inhib. of protein synth by binding to 30S rib. Mech.: O2 dependent uptake → inhib. of protein synth by binding to 30S rib.
subunit → leaky membranes. Bactericidal. subunit → leaky membranes. Bactericidal.
Absorption: Poor oral absorption. Usu. IM or IV. Absorption: Poor oral absorption. Usu. IM or IV.
Distribution: Limited to extracellular space. Poor CSF, ocular. No placenta. Distribution: Limited to extracellular space. Poor CSF, ocular. No placenta.
Excretion, t_: glomerular filtration. 2 hrs. Excretion, t_: glomerular filtration. 2 hrs.
Toxicity/S.E.s: Ototoxicity (aud., vest.), nephtrotoxicity. Toxicity/S.E.s: Ototoxicity (aud., vest.), nephtrotoxicity (less than gentamicin).
Utility: Nosocomial aerobic gram- infects, esp. in immunocomp, neutropenics. Utility: Nosocomial aerobic gram- infects, esp. in immunocomp, neutropenics.
Often used in synergistic combs to treat P. aeruginosa, enteroccus, life- Often used in synergistic combs to treat P. aeruginosa, enteroccus, life-
threatening gram- sepsis. Used in comb. against S. aureus. Ineffective threatening gram- sepsis. Used in comb. against S. aureus. Ineffective
against anaerobes. against anaerobes.
Special Features: Resistance 1° due to plasmid-med. mod. of aminoglyc. Also Special Features: Resistance 1° due to plasmid-med. mod. of aminoglyc. Also
alter. of transport system, mutation of rib. subunit. alter. of transport system, mutation of rib. subunit.
www.brain101.info
10
11. Name: Amikacin (Amikin) Name: Erythromycin
Class: Aminoglycoside Class: Macrolide
Mech.: O2 dependent uptake → inhib. of protein synth by binding to 30S rib. Mech.: Inhib protein synth by binding to 50S rib. subunit. Bacteriostatic
subunit → leaky membranes. Bactericidal. Absorption: Orally effective. Enteric-coated tablets.
Absorption: Poor oral absorption. Usu. IM or IV. Distribution: Good tissue penetration, but poor CSF.
Distribution: Limited to extracellular space. Poor CSF, ocular. No placenta. Metab.: Hepatic metab.
Excretion, t_: glomerular filtration. 2 hrs. Excretion, t_: Secreted in bile as active drug. 1.6 hr.
Toxicity/S.E.s: Ototox.(aud., vest.)(>than gent or tobr), nephtrotox.(<than gent.) Toxicity/S.E.s: GI irritation.,rashes, ototoxicity (large parenteral doses), drug
interactions due to inhib of hepatic metab.
Utility: Nosocomial aerobic gram- infects, esp. in immunocomp, neutropenics.
Often used in synergistic combs to treat P. aeruginosa, enteroccus, life- Utility: Alternate to pen. in mild-moderate infects (esp. Strep, H. influenzae).
threatening gram- sepsis. Used in comb. against S. aureus. Ineffective DOC for Legionnaire’s disease, Diphtheria carrier state, Mycoplasma
against anaerobes. pneumoniae infects, Whooping cough (Bordatella pertussis)
Special Features: Not recommended for severe staph. infections or for
Special Features: Resistance 1° due to plasmid-med. mod. of aminoglyc. Also
meningitis.
alter. of transport system, mutation of rib. subunit. Least
susceptible to resistance of the aminoglycs. Also, broadest
spectrum. Most expensive aminoglyc.
Name: Azithromycin (Zithromax) Name: Clindamycin (Cleocin)
Class: Macrolide (azalide) Class: Lincosamide
Mech.: Inhib protein synth by binding to 50S rib. subunit. Bacteriostatic Mech.: Inhib protein synth by binding to 50S rib. subunit. Bacteriostatic.
Absorption: Good oral. Better than erythromycin. Absorption: Nearly complete oral absorption. IV.
Distribution: Good tissue penetration. Better than erythromycin. Distribution: Good into most tissues, including bone. Poor CSF.
Metab.: Hepatic metab. Metab.: Hepatic metab.
Excretion, t_: Bile excretion. 68 hrs. Excretion, t_: Renal excretion. 2.7 hr.
Toxicity/S.E.s: fewer than erythromycin, esp. GI. No interference w/cytochrome Toxicity/S.E.s: High incidence of diarrhea. Antibiotic-assoc. pseudomembranous
p450 metab. colitis. Skin rashes. Local thrombophlebitis due to IV.
Utility: Alternate to pen. in mild-moderate infects (esp. Strep, H. influenzae). Utility: Alternate to pen. or eryth. in susceptible infections. One DOC for non-
DOC for Legionnaire’s disease, Diphtheria carrier state, Mycoplasma CNS anaerobic infections. Used topically for acne.
pneumoniae infects, Whooping cough (Bordatella pertussis) Special Features:
Special Features: Expanded spectrum over classic macrolides (more potent
against gram- bacilli, chlamydiae).
www.brain101.info
11
12. Name: Vancomycin (Vancocin) Name: Metronidazole (Flagyl)
Class: Polypeptide Class: Nitroimidazole derivative
Mech.: Blocks peptidoglycan polymerization → inhib cell wall synth. Bactericidal. Mech.: Inhib. DNA synth, degrades DNA, e- acceptor for reduced substrates.
Absorption: Poorly absorbed from GI tract. Usu given IV Absorption: Complete, quick oral absorption.
Distribution: Poor CNS Distribution: Well distrib to all tissues and fluids (including CSF)
Metab.: Metab.: Hepatic metab.
Excretion, t_: Renal excretion Excretion, t_:
Toxicity/S.E.s: Ototoxicity, nephrotoxicity, thrombophlebitis (IV). In patients Toxicity/S.E.s: GI, metallic taste, neurotox (vertigo), disulfiram-like effect
w/AIDS, “red man” syndrome (diffuse flushing) w/alcohol, neutropenia. Not for first trimester preg (mutagenic).
Not for patients w/active CNS disease or hist. of blood
Utility: Last ditch measure against severe MRSA infects. DOC for antibiotic dyscrasias.
assoc. pseudomembranous colitis (oral).
Utility: IV treatment of anaerobic infects. Oral for amebiasis, giardiasis, and
Special Features: Narrow spectrum (gram+ cocci), spec. MRSA, C. difficile. genital infects of Trichomonas vaginalis.
Special Features: Antiparasitic and antibacterial activity. All anaerobic cocci and
anaerobic gram- bacilli, including Bacteriodes.
Trichomonasis, amebiasis, giardiasis.
Name: Acyclovir (Zovirax) Name: Ganciclovir (Cytovene)
Class: Antiviral Class: Antiviral
Mech.: Inhib. DNA synthase (most selective for herpes virus). Phosphorylated Mech.: Phosph by viral thymidine kinase. Competes w/normal nucleotides.
by viral thymidine kinase. Then inhib. viral DNA polymerase by Prevents chain elongation upon incorporation. Also inhib. viral and
competing w/deoxyguanosine triphosphate. cellular DNA polymerase.
Absorption: Absorption: Poor oral. Usu. given IV.
Distribution:some CSF Distribution: Good CSF
Metab.: Metab.:
Excretion, t_: Renal secretion, 2.5 hr. Excretion, t_: Renal excretion. 4 hr.
Toxicity/S.E.s: Topical admin may cause loal irritation. IV may cause local Toxicity/S.E.s: Bone marrow suppression. Teratogenic and mutagenic in
phlebitis, rash. Encephalophaty in renal-impaired. experimental animals.
Utility: Topical, oral, IV application to treat herpes infections. Utility: Cytomegalovirus
Special Features: Special Features:
www.brain101.info
12
13. Name: Foscarnet (Foscavir) Name: Trifluridine (Viroptic)
Class: Antiviral Class: Antiviral
Mech.: Phosph by viral thymidine kinase. Competes w/normal nucleotides. Mech.: Pyrimidine analog. Competes with TTP for incorp into viral DNA. Inhib.
Prevents chain elongation upon incorporation. Also inhib. viral and viral DNA synth.
cellular DNA polymerase. Absorption:
Absorption: Poor oral. Usu. given IV. Distribution: 1% soln applied to cornea. Not given systemically
Distribution: Good CSF Metab.:
Metab.: Excretion, t_:
Excretion, t_: Renal excretion. 4 hr. Toxicity/S.E.s: Mutagenic and teratogenic activity in experimental tests.
Toxicity/S.E.s: Renal dysfxn #1. Nausea, vomiting, headache, fatigue, anemia. Utility: Topical treatment for keratoconjunctivitis.
Utility: Cytomegalovirus Special Features:
Special Features: 3x more expensive than gancyclovir.
Name: Interferon alpha 2b (Intron A) Name: Amantadine (Symmetrel)
Class: Antiviral Class: Antiviral/Antiparkinsonian Agent
Mech.: Bind to cell-surface receptors and inhibit viral penetration or uncoating, Mech.: Blocks a late stage in assembly of influenza A virus
synth or methylation of mRNA, translation of viral proteins, viral Absorption: Well absorbed orally.
assembly or release, and degrade mRNA. → Inhib. viral protein synth. Distribution:
Also induce a protein kinase that inactivates protein eIF-2 which is Metab.:
necessarty for protein synth initiation. Excretion, t_: Excreted unchanged in urine.
Absorption: Low oral activity. Usu. given IM or SC Toxicity/S.E.s: CNS toxicity (nervousness, confusion, hallucinations, insomnia,
Distribution: depression, confusion). Overdose → toxic psychosis. Freq. livedo
Metab.: Rapid degradation. reticularis (skin mottling). Peripheral edema, freq. nausea. C/I w/hist. of
seizures or congestive heart failure. Amantadine>rimantadine
Excretion, t_: 40 min.
Toxicity/S.E.s: influenza-like illness. Bone marrow suppression Utility: Treat influenza A. Treat Parkinson’s Disease symptoms → improvement
w/granulocytopenia and thrombocytopenia. Antibodies develop o akinesia, rigidity, tremor, gait disturbances, & total disability in ~ 50%
of patients (mech. unknown). Use alone or w/L-Dopa for PD.
w/continued use. Continued nasal admin → mucosal damage.
Features: Can be used prophylactically for influenza A. For PD, sustained
Utility: Treat hepatitis B and C improvement may last up to 30 months, but may also be short lived (1-3
months). For PD, as good as or better than anticholinergics.
www.brain101.info
13
14. Name: Rimantadine (Flumadine) Name: Ribavirin (Virazole)
Class: Antiviral Class: Antiviral
Mech.: Blocks a late stage in assembly of influenza A virus Mech.: Purine analog. After phosphorylation, inhibits enzymes involved in
Absorption: Well absorbed orally. guanine nucleotide synth. After further phosph, inhib several viral-
specific enzymes involved in DNA synth.
Distribution:
Absorption: Oral bioavail 45%. IV. Aerosol.
Metab.: Hepatic metab.
Distribution:
Excretion, t_:
Metab.:
Toxicity/S.E.s: CNS toxicity (nervousness, confusion, hallucinations, insomnia)
amantadine>rimantadine Excretion, t_: 40 days
Utility: Treat influenza A Toxicity/S.E.s: Accumulates in erythrocytes → hemolytic anemia. Bone marrow
Special Features: Can be used prophylactically. suppression. GI, CNS aggravation. Teratogenic and mutagenic
in animals. Toxicity avoided w/aerosol admin (for RSV).
Antagonizes AZT activity.
Utility: Aerosol form used to treat respiratory syncytial virus. Most important
drug for treatment of hemorrhagic fever.
Special Features:
Name: Azidothymidine (Zidovudine, AZT) Name: Dideoxyinosine (Didanosine, Videx, DDI)
Class: Antiviral Class: Antiviral
Mech: Thymidine analog. After phosph, inhib. viral RNA-dependent DNA Mech.: Inhib reverse transcriptase.
polymerase (reverse transcriptase). Causes chain termination after Absorption:
incorporation.
Distribution:
Absorption: Oral bioavail 60-65%.
Metab.:
Distribution: good CSF
Excretion, t_:
Metab.: Metab. to glucuronide. Antag. by ribavirin
Toxicity/S.E.s: Peripheral neuropathy, rash, stomatitis, esophageal ulceration,
Excretion, t_: 1 hr. pancreatitis, fever.
Toxicity/S.E.s: Granulocytopenia (45%), anemia (transfusions necessary 30%), Utility: Treat HIV. Strains resistant to AZT may be susceptible. After treatment,
headache, nausea, insomnia, myalgia. may become susceptible again to AZT. Alternating treatment superior to
Utility: Treatment of HIV. Decreases plasma HIV RNA, increases CD4 cells, either alone.
decreases # of opportunistic infects, prolongs survival. Reduces risk of Special Features:
transmission by pregnant women to fetuses from 28% to 8%.
Special Features:
www.brain101.info
14
15. Name: Dideoxycytosine (Zalcitabine, Hivid, DDC)) Name: Indinavir (Crixivan)
Class: Antiviral Class: Antiviral
Mech.: Inhib reverse transcriptase. Mech.: Inhib HIV protease activity
Absorption: Absorption: Oral
Distribution: Distribution:
Metab.: Metab.:
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: Peripheral neuropathy, rash, stomatitis, esophageal ulceration, Toxicity/S.E.s:
pancreatitis, fever. Utility: Treat HIV
Utility: Treat HIV. Strains resistant to AZT may be susceptible. After treatment, Special Features: Active against strains resistant to reverse transcriptase
may become susceptible again to AZT. Alternating treatment superior to inhibitors.
either alone.
Special Features:
Name: Ritonavir (Norvir) Name: Saquinavir (Invirase)
Class: Antiviral Class: Antiviral
Mech.: Inhib HIV protease activity Mech.: Inhib HIV protease activity
Absorption: Oral Absorption: Oral
Distribution: Distribution:
Metab.: Metab.:
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: Toxicity/S.E.s:
Utility: Treat HIV Utility: Treat HIV
Special Features: Active against strains resistant to reverse transcriptase Special Features: Active against strains resistant to reverse transcriptase
inhibitors. inhibitors.
www.brain101.info
15
16. Name: Isoniazid (INH) Name: Rifampin (Rifadin)
Class: Antitubercular Class: Antitubercular
Mech.: Tuberculostatic to resting bacilli, tuberculocidal to rapidly dividing cells. Mech.: Inhib. of bact. DNA-dependent RNA polymerase. Resist develops rapidly.
Enters cells via active uptake. Interferes w/DNA synth, glycolyis, Absorption: Orally effective
synth of mycolic acid (unique component of mycobacteria)
Distribution: Diffuses freely into tissues and fluids
Absorption: Rapidly absorbed after oral admin.
Metab.: Liver
Distribution: Distributes in total body water. Retained in infected tissue.
Excretion, t_: 30% excreted in urine (50% active). T1/2= 1.5-5 hrs. ↓ in slow
Metab.: Acetylated in liver.
acetylaters.
Excretion, t_: Urine. 75-90% in urine as metabolites in 24 hrs.
Toxicity/S.E.s: Low incidence. Jaundice (can be fatal). Use w/caution
Toxicity/S.E.s: Direct—inactivation/depletion of pyridoxine → peripheral neuritis w/impaired liver fxn. Induces hepatic microsomal enzymes. GI
(treat prophylactically w/supplemental pyridoxine). distress, diarrhea, CNS complaints, hypersensitivity. Influenza-
Hypersensitivity rxns. Hepatitis (can be fatal) due to toxic like syndrome.
metabolites. Convulsions, optic neuritis, toxic encephalopathy, Utility: Rapidly improves TB patients to non-infectious state. Always used
reversible psychotic episodes. w/other agents. Esp. useful in serious cases of TB. Asymptomatic
Utility: Most important and widely used drug for tuberculosis. Prob. w/resistance. carriers of N. meningitis, eryth-resist. Legionella pneumophila infects.
Special Features: Only drug approved for prophylaxis of tuberculosis. DOC for prophylaxis of H. influenza meningitis.
Name: Ethambutol (Myambutol) Name: Pyrazinamide
Class: Antitubercular Class: Antitubercular
Mech.: Tuberculostatic, mech. unknown, may involve inhib of mycolic acid synth. Mech.: Bactericidal. Unknown mech.
Absorption: Well absorbed orally. Not affected by food. Absorption: Well absorbed orally. Not affected by food.
Distribution: Distribution: Dist. in total body water.
Metab.: Metab.: Partially metabolized — hydrolyzed, hydroxylated
Excretion, t_: Renal excretion (50% unchanged and 15% inactive metab. in 24 hr) Excretion, t_: Glomerular filtration. 8 hrs.
Toxicity/S.E.s: Few. Decreased visual acuity and ability to perceive color green Toxicity/S.E.s: Liver necrosis, hyperuricemia, nausea, vomiting, complication of
(usually reversible). Gout. diabetes management.
Utility: Treat TB. Resistance develops is used alone. Usu. used with isoniazid. Utility: Used to treat TB when there is resistance to other agents. Requires 3
Special Features: additional effective agents.
Special Features:
www.brain101.info
16
17. Name: Amphotericin B (Fungizone) Name: Nystatin
Class: Antifungal (Polyene)
Class: Antifungal (Polyene)
Mech.: Assoc. w/ergosterol in fungal membrane → 4-5 Å pores. Fungistatic at
low conc. Fungicidal at high conc. Mech.: Assoc. w/ergosterol in fungal membrane → 4-5 Å pores. Fungistatic at
Absorption: Insoluble in water. Colloidal preparation injected IV. Not absorbed low conc. Fungicidal at high conc.
orally, IM, or after bladder irrigation. Used topically. Absorption: Poor oral absorption. Topical admin.
Distribution: Bound to cholesterol and lipoprotiens. Poor CSF. Intrathecal may
Distribution:
be necessary to treat meningitis.
Excretion, t_: Excreted very slowly as inactive metabolite by kidney. Metab.:
Toxicity/S.E.s: Nephrotoxicity (80%) requires hospitalization for administration. Excretion, t_:
Chills (50%), fever, nausea, vomiting, diarrhea, headache, Toxicity/S.E.s: No side effects when topically applied
phlebitis, suppression of RBC synth. IT → headache, radiculitis,
Utility: Superficial candidiasis (GI, cutaneous, oropharyngeal, vulvovaginal) via
paresis, paresthesias, visual impairment. topical, oral, or vaginal admin.
Utility: 1° drug used against serious systemic infections. DOC for 1° amebic
Special Features: Safe during pregnancy.
meningoencephalitis caused by Naegleria. Alt. for American cutaneous
or mucocutaneous leishmoniasis. Weekly injections for chronic
suppression of Histoplasmosis in AIDS patients.
Special Features: No problem w/resistance development. Increases fungal
permeability to other agents.
Name: Flucytosine (Ancobon) Name: Ketoconazole (Nizoral)
Class: Antifungal Class: Antifungal (Imidazole)
Mech.: Converted to 5-fluorouracil in fungi (enzyme not in humans). 5-fluorouracil Mech.: Interferes w/ergosterol synth → altered fungal membrane permeability.
→ phosph deoxyribose that inhibits thymidylate synth. Fungistatic. Absorption: Absorbed well from GI if contents are sufficiently acidic.
Absorption: Well absorbed orally. Distribution: Poor CSF at recommended doses. Ok CSF w/high doses.
Distribution: Passes BBB (75%) → good CSF. Aqueous humor, bronchial Metab.: Degraded by liver.
secretions. Poorly bound by serum proteins. Excretion, t_: Excreted mostly into bile. Only 10-15% appears unchanged in
Metab.: urine. Excreted in milk.
Toxicity/S.E.s: Fewer than Amphoter. or flucytosine. Rare fatal hepatic
Excretion, t_: 1° glomerular filtration (unmetab. product). 3-4 hr → 200 hr w/renal
necrosis. Dose-dependent decrease in testosterone. Toxicities
failure. Dose must be adjusted if renal fxn compromised. for nursing infants. Rare anaphylactic shock. Can’t be used
Toxicity/S.E.s: Bone marrow depression with anemia, thrombocytopenia, w/astemizole, terfenadine, loratadine due to inhib. of
leukopenia. Nausea, rashes, eosinophilisa, severe diarrhea,
reversible hepatic dysfxn. Confusion, hallucinations, headache, metabolism. Coadmin. w/ketoconazole → ↑ conc. of
vertigo, possibly fatal enterocolitis (esp. in comb. w/Amphoter.). cyclosporin. Increases anticoag. response of anticoag drugs.
Utility: DOC for Chromomycosis. Used in comb. w/Amph for systemic Candida Coadmin w/isoniazid or rifampin → ↓ ketoconazole.
Albicans. Utility: DOC for Pseudoallescheria boydii. Alternate for C. albicans, H.
Special Features: Narrower spectrum than Amphotericin B. Resistance develops capsulatum, B. dermatidis, Paracoccidiodes, C. immitis.
rapidly, so usu. used in comb., except to treat Special Features: Very broad spectrum. Being phased out and replaced with
Chromomycosis itraconazole and fluconazole.
www.brain101.info
17
18. Name: Itraconazole (Sporanox) Name: Fluconazole (Diflucan)
Class: Antifungal (Triazole)
Class: Antifungal (Triazole)
Mech.: Inhib. fungal cyt. P450 and sterol C-14 α-demethylation. Normal sterols
Mech.: Inhib. cytochrome P450-dependent synth of ergosterol.
depleted, 14-α-methyl sterols build up → fungistatic.
Absorption: Oral absorption good. Better in presence of food, high gastric
acidity. Absorption: Oral absorption ≅ IV absorption (rare phenom.)
Distribution: Low plasma protein binding. Vd close to total body water. Good
Distribution: Neglibible CSF, saliva. saliva, good CSF (~80%), conc. in urine and skin.
Metab.: Extensively metab. in liver. Metab.:
Excretion, t_: Very little active drug remains in urine. Excretion, t_: 80% appears in urine unchanged. Excreted in milk. 30 hr.
Toxicity/S.E.s: Rare hepatotoxicity. Rare exfoliative skin disorders (can be
Toxicity/S.E.s: Nausea, vomiting, headache, rash, loss of libido, impotence,
fatal). GI irritation, rash. Affects rat fetal development.
gynecomastia. Rare hepatotoxicity. Inhib. metab. of long-acting
Increases metabolite levels of some terfenadine metabolits (not
antihistamines (sim. to ketoconazole), erythromycin, triazolam,
terf. itself). May slow metab. of long-acting antihistamines and
cisapride.
cyclosporines.
Utility: DOC for many superficial and systemic infections. Alternate for many Utility: Candidiasis (oropharyngeal, esophageal, UTI, vaginal, systemic),
superf. and systemic infections. Oral treatment of onychomycoses. Cryptococcal meningitis in AIDS patients and otherwise healthy patients.
Same indications as ketocon., but also active against lymphocutaneous Coccidiodal meningitis. Chronic suppresion of Crypt. meningitis in AIDS
form of sporotrichosis plus Aspergillosis. Usu. preferred to patients. Single-dose therapy for vaginal yeast infections.
ketoconazole. Special Features: Oral absorption ≅ IV absorption. Only causes minor changes in
Special Features: plasma testosterone and corticosteroid concentrations.
Name: Griseofulvin (Grifulvin) Name: Miconazole (Monistat, OTC=Micatin)
Class: Antifungal Class: Antifungal (Imidazole)
Mech.: Binds to microtubules, disrupts mitotic spindle, blocks mitosis. Mech.: Causes leakage of small molecules/ions across plasma membrane. Also
Fungistatic. blocks purine uptake. Fungistatic at low conc. Fungicidal at high
conc.
Absorption: Always given orally. Erratically absorbed. Fatty meals → ↑
absorption. Absorption: Good oral, but not admin due to GI irritation. Topical, IV, IT.
Distribution: Binds in high conc. to keratin in areas of skin, hair, nails most Distribution: Good CSF
affected by dermatophytes. Toxicity/S.E.s: Topical → occasional burning and irritation. IV/IT may cause
Metab.: cardiorespiratory failure, thrombophlebitis.
Toxicity/S.E.s: Headache, rare CNS effects (memory lapse, impaired judgment, Utility: Topical against common fungal infections of skin and vagina. Better than
blurred vision. Candida superinfection. High doses nystatin for vaginal candidiasis. Esp. useful in mixed skin infections
carcinogenic, teratogenic. Disulfiram-like effect with alcohol. featuring dermatophytes and Candida. Best topical agent for
Reduces efficacy of some oral contraceptives. dermatophytoses (even severe). Efficacy = 90%. IV/IT as alternative
Utility: Inhibits most dermatophytes and superfic. yeast infections. Treats most for systemic Pseudallescheriasis infection (only non-topical use).
types of tinea, ringworm, athletes foot. Special Features: Safe during pregnancy. Broad spectrum against fungi. Also
Special Features: Cures at the base of the problem. When the cured base grow active against gram+ bacteria.
completely out, patient is cured. Long eradication time. Poor
cure rate.
www.brain101.info
18
19. Name: Clortrimazole (Lotrimin) Name: Ciclopirox (Loprox)
Class: Antifungal (Imidazole) (OTC) Class: Antifungal (OTC)
Mech.: Causes leakage of small molecules/ions across plasma membrane. Also Mech.:
blocks purine uptake. Fungistatic at low conc. Fungicidal at high conc. Absorption: Penetrates dermis, hair follicles, sebaceous glands.
Absorption: Good oral, but not admin due to GI irritation. Topical. Distribution:
Distribution: Good CSF Metab.:
Toxicity/S.E.s: Topical → occasional burning and irritation. Excretion, t_:
Utility: Topical against common fungal infections of skin and vagina. Better than Toxicity/S.E.s:
nystatin for vaginal candidiasis. Esp. useful in mixed skin infections Utility: 81-94% cure rate for cutaneous candidiasis, tinea corporis, tinea pedis,
featuring dermatophytes and Candida. Good topical agent for versicolor. May (one report) be useful in topical treatment of
dermatophytoses. Troches esp. recommended for oropharyngeal onychomycosis.
candidiasis.
Special Features:
Special Features: Safe during pregnancy. Broad spectrum against fungi. Also
active against gram+ bacteria. At high conc, also
trichomonocidal.
Name: Tolnaftate (Aftate, Tinactin) Name: Undecylenic Acid (Desenex)
Class: Antifungal (OTC) Class: Antifungal (OTC)
Mech.: Mech.:
Absorption: Absorption:
Distribution: Distribution:
Metab.: Metab.:
Excretion, t_: Excretion, t_:
Toxicity/S.E.s: Toxicity/S.E.s:
Utility: 80% efficacy against dermatophytes Utility: <50% efficacy against athlete’s foot
Special Features: Special Features:
www.brain101.info
19
20. Name: Iodide
Class: Antifungal? Halide?
Mech.:
Absorption:
Distribution:
Metab.:
Excretion, t_:
Toxicity/S.E.s:
Utility: Used as alternate treatment for superficial cutaneous Sporotrichosis.
Special Features:
www.brain101.info
20